Teva has eliminated the core RICO exposure in this case, removing a significant litigation overhang. Monitor the separate order on state-law claims for any remaining financial exposure. The ruling reinforces Teva's legal position in similar co-pay charity cases and removes a key uncertainty for the stock.
Price Chart
Executive Summary
Teva won summary judgment dismissing United Healthcare's RICO claims as time-barred. The court held that storm warnings — including a 2005 WSJ article quoting a Teva executive, extensive media coverage, and the 2017 IRS investigation into Teva's Copaxone co-pay charity donations — put United on inquiry notice by November 2018, four years before it sued. The ruling eliminates material RICO exposure for Teva, though state-law claims remain pending in a separate order.
Court Ruling Details
Key Facts
- Teva's motion for summary judgment on statute-of-limitations grounds was GRANTED as to all federal RICO claims.
- The court found storm warnings existed by November 2018 — including a 2005 WSJ article quoting a Teva executive, 2013-2017 media coverage, and the 2017 IRS investigation into Teva's donations to the Chronic Disease Fund (CDF) for Copaxone co-pays.
- The Teva-CDF donation agreement, publicly filed in 2017, explicitly stated CDF would use Teva donations to cover Copaxone co-pays and provide detailed weekly/monthly reports to Teva.
- The court held that United Healthcare, as a sophisticated insurer, should have known of these warnings and that its RICO claims were filed too late.
- State-law claims (fraudulent concealment, tortious interference, unjust enrichment, consumer protection) were addressed in a separate order and remain pending.
- No damages were awarded; the ruling eliminates the RICO claims entirely.
Financial Impact
RICO claims dismissed — no damages awarded. The complaint sought unspecified millions in alleged overpayments for Copaxone. State-law claims remain pending.
Risk Factors
- State-law claims remain pending and could still result in damages or settlement costs.
- The ruling may be appealed by United Healthcare to the Third Circuit.
- Other insurers may bring similar claims based on the same alleged conduct, though this ruling creates a strong statute-of-limitations defense.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion from CourtListener.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-12221f377c-TEVA |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 22d ago | Press Release | $36.35 $39.19 | ▲ +7.81% | ▲ +8.31% | $39.51 (+8.69%) |
Sep 8, 2026 24d ago | 424B5 | $36.76 $39.25 | ▲ +6.77% | ▲ +7.89% | $39.51 (+7.48%) |
Sep 2, 2026 4w ago | Court Ruling | $37.49 $36.35 | ▼ −3.04% | ▼ −2.08% | $39.51 (+5.39%) |
Aug 28, 2026 5w ago | Press Release | $36.44 $36.36 | ▼ −0.22% | ▼ −0.33% | $39.51 (+8.42%) |
Aug 25, 2026 5w ago | Court Ruling | $38.10 $36.20 | ▼ −4.99% | ▼ −4.46% | $39.51 (+3.70%) |
Aug 25, 2026 5w ago | Insider Cluster | $38.10 $36.20 | ▼ −4.99% | ▼ −4.46% | $39.51 (+3.70%) |
Aug 10, 2026 7w ago | Insider Cluster | $36.14 $36.46 | ▲ +0.89% | ▲ +0.93% | $39.51 (+9.32%) |
Aug 5, 2026 8w ago | Insider Cluster | $34.81 $36.45 | ▲ +4.70% | ▲ +3.49% | $39.51 (+13.50%) |
Jul 31, 2026 9w ago | Court Ruling | $35.01 $35.36 | ▲ +1.00% | ▼ −2.51% | $39.51 (+12.85%) |
Jul 29, 2026 9w ago | 8-K | $34.71 $34.72 | ▲ +0.03% | ▼ −5.50% | $39.51 (+13.83%) |
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access